The relative efficiency of time-to-progression and continuous measures of cognition in pre-symptomatic Alzheimer's

Dan Li, Samuel Iddi, Paul S. Aisen +2

Pre-symptomatic (or Preclinical) Alzheimer's Disease is defined by biomarker evidence of fibrillar amyloid beta pathology in the absence of clinical symptoms. Clinical trials in th…